Micronized fenofibrate: Phase IV; marketed as adjunct to treat primary hypercholesterolemia

Researchers reported in The Lancet results from an international, placebo-controlled post-marketing study

Read the full 123 word article

How to gain access

Continue reading with a
two-week free trial.